An investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) was generally well tolerated and resulted in the production of both binding and neutralizing antibodies in healthy adult volunteers, according to interim results from a phase 1 trial published today. at New England Journal of Medicine. The experimental vaccine …
Read More »Moderna rises 18% according to the report that the shares will join the Nasdaq 100 and, as the analyst predicts an increase of 45%
The Nasdaq announced Monday that Moderna will be added to its Nasdaq 100 index in July. Moderna’s shares rose as much as 18% on Monday. On Monday, Jefferies kicked off Moderna’s coverage with a “buy” rating and a target price of $ 90 over the approval potential of the pharmaceutical …
Read More »Houston research company selected for the COVID-19 vaccine trial; asking for the participants
HOUSTON, Texas (KTRK) – A Houston research company has been selected for the COVID-19 vaccine trials and is asking for volunteers to be part of it. The Texas Center for Drug Development, also known as TCDD, is asking people to participate in the trials, which will take place in a …
Read More »Houston research company selected for the COVID-19 vaccine trial; asking for the participants
HOUSTON, Texas (KTRK) – A Houston research company has been selected for the COVID-19 vaccine trials and is asking for volunteers to be part of it. The Texas Center for Drug Development, also known as TCDD, is asking people to participate in the trials, which will take place in a …
Read More »A panel of outside government experts could determine who gets the COVID-19 vaccine first, says NIH director
Public health officials told a Senate committee Thursday that a panel of experts outside the United States government can help decide who gets the COVID-19 vaccine first. Dr. Francis Collins, Director of the National Institutes of Health, acknowledged that the public might be wary of the US government having the …
Read More »